Drug-Eluting Stents: Technical and Clinical Progress

被引:16
作者
Kozlik, Maciej [1 ]
Harpula, Jan [1 ]
Chuchra, Piotr J. [2 ]
Nowak, Magdalena [2 ]
Wojakowski, Wojciech [1 ]
Gasior, Pawel [1 ]
机构
[1] Med Univ Silesiaia, Div Cardiol & Struct Heart Dis, PL-40635 Katowice, Poland
[2] Med Univ Silesiaia, Fac Med Sci Katowice, Dept Cardiol, Students Sci Soc, PL-40635 Katowice, Poland
关键词
drug-eluting stents; scaffold; overexpansion; drug; polymer; coating technique; CORONARY-ARTERY-DISEASE; ANGIOGRAPHIC FOLLOW-UP; BIODEGRADABLE POLYMER; BARE-METAL; OVER-EXPANSION; SIROLIMUS; OUTCOMES; RESTENOSIS; METAANALYSIS; THROMBOSIS;
D O I
10.3390/biomimetics8010072
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous revascularization procedures. The design of the stent platforms is constantly improving to maximize its efficacy and safety. Constant development of DES includes adoption of new materials used for scaffold production, new design types, improved overexpansion abilities, new polymers coating and, finally, improved antiproliferative agents. Especially nowadays, with the immense number of available DES platforms, it is crucial to understand how different aspects of stents impact the effect of their implantation, as subtle differences between various stent platforms could impact the most important issue-clinical outcomes. This review discusses the current status of coronary stents and the impact of stent material, strut design and coating techniques on cardiovascular outcomes.
引用
收藏
页数:16
相关论文
共 93 条
  • [1] Abbott Vascular, XIENCE SKYP EV EL CO
  • [2] Abreu-Silva Erlon O. de, 2012, Rev. Bras. Cardiol. Invasiva, V20, P146, DOI 10.1590/S2179-83972012000200007
  • [3] Allocco D.J., 2011, INTERVENT CARDIOL, V6, P134, DOI 10.15420/icr.2011.6.2.134
  • [4] [Anonymous], 2018, CIRC-CARDIOVASC INTE, V12, P66
  • [5] Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan
    Aoki, Jiro
    Kozuma, Ken
    Awata, Masaki
    Nanasato, Mamoru
    Shiode, Nobuo
    Tanabe, Kengo
    Yamaguchi, Junichi
    Kusano, Hajime
    Nie, Hong
    Kimura, Takeshi
    [J]. CIRCULATION JOURNAL, 2016, 80 (04) : 906 - +
  • [6] BALTON, ALEX SIR EL COB CHRO
  • [7] Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
    Bangalore, Sripal
    Kumar, Sunil
    Fusaro, Mario
    Amoroso, Nicholas
    Attubato, Michael J.
    Feit, Frederick
    Bhatt, Deepak L.
    Slater, James
    [J]. CIRCULATION, 2012, 125 (23) : 2873 - +
  • [8] Becker RC, 2015, CIRCULATION, V131, P2010, DOI 10.1161/CIRCULATIONAHA.114.013281
  • [9] BioFreedomTM, BIOFREEDOM DRUG COAT
  • [10] Optimization of Drug Delivery by Drug-Eluting Stents
    Bozsak, Franz
    Gonzalez-Rodriguez, David
    Sternberger, Zachary
    Belitz, Paul
    Bewley, Thomas
    Chomaz, Jean-Marc
    Barakat, Abdul I.
    [J]. PLOS ONE, 2015, 10 (06):